Campbell & Co Investment Adviser’s Aurinia Pharmaceuticals AUPH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189K	Buy	+11,163	New	+$178K	0.01%	982
2026 Q1	–	Sell	-20,675	Closed	-$330K	–	1065
2025 Q4	$330K	Sell	20,675 -9,504	-31%	-$135K	0.02%	954
2025 Q3	$333K	Sell	30,179 -9,586	-24%	-$105K	0.03%	876
2025 Q2	$337K	Sell	39,765 -4,307	-10%	-$34.5K	0.02%	917
2025 Q1	$354K	Buy	+44,072	New	+$357K	0.03%	802
2024 Q3	–	Sell	-19,597	Closed	-$112K	–	1083
2024 Q2	$112K	Sell	19,597 -217,498	-92%	-$1.15M	0.01%	999
2024 Q1	$1.19M	Buy	237,095 +4,684	+2%	+$31.8K	0.1%	323
2023 Q4	$2.09M	Buy	+232,411	New	+$1.91M	0.19%	121

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Campbell & Co Investment Adviser's AUPH Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 11,163 shares worth $189K. The stake represents 0.01% of the portfolio and ranks #982 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in AUPH as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in AUPH in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.09M in Q4 2023. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Campbell & Co Investment Adviser held 11,163 shares of Aurinia Pharmaceuticals worth $189K as of Q2 2026.
Aurinia Pharmaceuticals was a new Campbell & Co Investment Adviser position in Q2 2026.
Aurinia Pharmaceuticals made up 0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #982 holding.
Campbell & Co Investment Adviser first reported a position in Aurinia Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
Campbell & Co Investment Adviser's Aurinia Pharmaceuticals position peaked at $2.09M in Q4 2023.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.